PARCIVAL

Partner Network for a Clinically Validated Multi-Analyte Lab-on-a-Chip Platform

Coordinatore	ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM    more  Organization address address: 's Gravendijkwal 230 city: ROTTERDAM postcode: 3015CE contact info Titolo: Prof. Nome: Willem Cognome: Van Leeuwen Email: send email Telefono: 31107033510
Nazionalità Coordinatore	Netherlands [NL]
Totale costo	4˙132˙600 €
EC contributo	2˙973˙550 €
Programma	FP7-HEALTH Specific Programme "Cooperation": Health
Code Call	FP7-HEALTH-2011-two-stage
Funding Scheme	CP-FP
Anno di inizio	2012
Periodo (anno-mese-giorno)	2012-01-01   -   2014-12-31

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM  Organization address address: 's Gravendijkwal 230 city: ROTTERDAM postcode: 3015CE contact info Titolo: Prof. Nome: Willem Cognome: Van Leeuwen Email: send email Telefono: 31107033510	NL (ROTTERDAM)	coordinator	353˙400.00
2	HAHN-SCHICKARD-GESELLSCHAFT FUER ANGEWANDTE FORSCHUNG E.v.  Organization address address: WILHELM-SCHICKARD-STRASSE 10 city: Villingen postcode: 78052 contact info Titolo: Ms. Nome: Saskia Cognome: Scherer Email: send email Telefono: +49 7721 943 158 Fax: +49 7721 943 140	DE (Villingen)	participant	553˙750.00
3	PATHOFINDER HOLDING BV  Organization address address: RANDWYCKSINGEL 45 city: MAASTRICHT postcode: 6229 EG contact info Titolo: Dr. Nome: Guus Cognome: Simons Email: send email Telefono: +31 43 3885851	NL (MAASTRICHT)	participant	420˙000.00
4	Askion GmbH  Organization address address: GEWERBEPARK KEPLERSTRASSE 17-19 city: GERA postcode: 7549 contact info Titolo: Mr. Nome: Lutz Cognome: Doms Email: send email Telefono: 493657000000 Fax: 493657000000	DE (GERA)	participant	400˙000.00
5	AGROBIOGEN GMBH BIOTECHNOLOGIE  Organization address address: LAREZHAUSEN 2 city: HILGERTSHAUSEN postcode: 86567 contact info Titolo: Prof. Nome: Gottfried Cognome: Brem Email: send email Telefono: 4982510000000	DE (HILGERTSHAUSEN)	participant	376˙000.00
6	AIRBUS DEFENCE AND SPACE GMBH  Organization address address: WILLY MESSERSCHMITT STRASSE 1 city: OTTOBRUNN postcode: 85521 contact info Titolo: Dr. Nome: Alois Cognome: Friedberger Email: send email Telefono: 498961000000	DE (OTTOBRUNN)	participant	330˙000.00
7	ROHRER AG WERKZEUG- & MASCHINENBAU  Organization address address: BREMENSTALLSTRASSE 1 city: MOHLIN postcode: 4313 contact info Titolo: Mr. Nome: Hans Cognome: Peter Email: send email Telefono: 41618552185	CH (MOHLIN)	participant	295˙400.00
8	INSTITUTUL NATIONAL DE CERCETAREDEZVOLTARE PENTRU MICROTEHNOLOGIE  Organization address address: Erou iancu Nicolae Street 32B city: "VOLUNTARI, BUCHAREST" postcode: 77190 contact info Titolo: Dr. Nome: Carmen Cognome: Moldovan Email: send email Telefono: 40212690770 Fax: 40212690776	RO ("VOLUNTARI, BUCHAREST")	participant	205˙000.00
9	MEDIZINISCHES VERSORGUNGZENTRUM DRSTEIN + KOLLEGEN LABORATORIUMSMEDIZIN MIKROBIOLOGIE INFEKTIONSEPIDEMIOLOGIE VIROLOGIE TRANSFUSIONSMEDIZIN  Organization address address: WALLSTRASSE 10 city: MONCHENGLADBACH postcode: 41061 contact info Titolo: Dr. Nome: Lothar Cognome: Kruska Email: send email Telefono: 49216181940	DE (MONCHENGLADBACH)	participant	40˙000.00

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'The objective of PARCIVAL is to develop an integrated and automated multi-analyte lab-on-a-disk platform for the fast and reliable sample in -> answer out diagnosis of highly infectious respiratory pathogens, resistance patterns and biomarkers for individual severity of the infection. The platform format will be based on completely integrated microfluidic foil-disposables. The disposables will feature different panels (selection of pathogens, resistance patterns, biomarkers), which can be freely selected and combined to allow a comprehensive choice of diagnostic parameters by the clinician at the point-of-care, vastly increasing the access to diagnostic information for doctors in everyday situations and emergencies. The integrated platform with pre-packaged liquid and dry reagents will automate all processing steps from sample preparation, over assay processing up to result reporting.

This will allow evidence-based therapeutic decisions, allow antibiotic prescriptions which are tailored to the individual patient and thus offer the prospect to greatly improve therapeutic outcomes. Also, an air-sampling add-on module for monitoring of clinical ventilation systems will be developed and interfaced to the platform. By acting as early warning system that is able to identify airborne pathogens including resistances, this will increase the impact towards the topic 2.3.1-4 (“retard the development of multi-drug resistance”) as well as the area 2.3.1 (“development of effective infection prevention and control strategies”).

The consortium consists of 9 partners (6 enterprises (4 SMEs), 3 institutes). The project is heavily based on the research capabilities of innovative SMEs. Therefore, SMEs will be the main beneficiaries of exploitation in the project. The key-developments of involved European SMEs will support European companies to establish a leading role in the field lab-on-a-chip applications which is based on the huge in vitro diagnostics market.'